94.38MMarket Cap-243P/E (TTM)
0.480High0.430Low3.78MVolume0.450Open0.438Pre Close1.71MTurnover2.21%Turnover RatioLossP/E (Static)207.51MShares1.67052wk High1.67P/B77.75MFloat Cap0.29152wk Low--Dividend TTM170.95MShs Float51.375Historical High--Div YieldTTM11.45%Amplitude0.291Historical Low0.451Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet